Report Detail

The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
According to our (Global Info Research) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at USD 6459.6 million in 2022 and is forecast to a readjusted size of USD 11310 million by 2029 with a CAGR of 8.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of Isothermal Nucleic Acid Amplification Technology (INAAT) include Abbott, BioMerieux and Hologic, etc. Global top three manufacturers hold a share over 70%. North America is the largest market of Isothermal Nucleic Acid Amplification Technology (INAAT), with a share nearly 80%, followed by Europe.
This report is a detailed and comprehensive analysis for global Isothermal Nucleic Acid Amplification Technology (INAAT) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Isothermal Nucleic Acid Amplification Technology (INAAT) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Isothermal Nucleic Acid Amplification Technology (INAAT) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Isothermal Nucleic Acid Amplification Technology (INAAT) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Isothermal Nucleic Acid Amplification Technology (INAAT) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Isothermal Nucleic Acid Amplification Technology (INAAT)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BioMerieux, Hologic, BD and Grifols, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Isothermal Nucleic Acid Amplification Technology (INAAT) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
LAMP
TMA
NEAR
NASBA
HDA
SPIA
Other
Market segment by Application
Medical Diagnostic
Scientific Research
Food Testing
Environmental Hygiene
Other
Market segment by players, this report covers
Abbott
BioMerieux
Hologic
BD
Grifols
Quidel
Meridian Bioscience
Qiagen
Eiken Chemical
OptiGene
HiberGene Diagnostic
Lucigen
Nippon Gene
Mast Group
New England Biolabs
Ustar Biotechnologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Isothermal Nucleic Acid Amplification Technology (INAAT) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Isothermal Nucleic Acid Amplification Technology (INAAT), with revenue, gross margin and global market share of Isothermal Nucleic Acid Amplification Technology (INAAT) from 2018 to 2023.
Chapter 3, the Isothermal Nucleic Acid Amplification Technology (INAAT) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Isothermal Nucleic Acid Amplification Technology (INAAT) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Isothermal Nucleic Acid Amplification Technology (INAAT).
Chapter 13, to describe Isothermal Nucleic Acid Amplification Technology (INAAT) research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Isothermal Nucleic Acid Amplification Technology (INAAT)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Isothermal Nucleic Acid Amplification Technology (INAAT) by Type
    • 1.3.1 Overview: Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value Market Share by Type in 2022
    • 1.3.3 LAMP
    • 1.3.4 TMA
    • 1.3.5 NEAR
    • 1.3.6 NASBA
    • 1.3.7 HDA
    • 1.3.8 SPIA
    • 1.3.9 Other
  • 1.4 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application
    • 1.4.1 Overview: Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Medical Diagnostic
    • 1.4.3 Scientific Research
    • 1.4.4 Food Testing
    • 1.4.5 Environmental Hygiene
    • 1.4.6 Other
  • 1.5 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size & Forecast
  • 1.6 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast by Region
    • 1.6.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region, (2018-2029)
    • 1.6.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Prospect (2018-2029)
    • 1.6.6 South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.1.4 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Abbott Recent Developments and Future Plans
  • 2.2 BioMerieux
    • 2.2.1 BioMerieux Details
    • 2.2.2 BioMerieux Major Business
    • 2.2.3 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.2.4 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BioMerieux Recent Developments and Future Plans
  • 2.3 Hologic
    • 2.3.1 Hologic Details
    • 2.3.2 Hologic Major Business
    • 2.3.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.3.4 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Hologic Recent Developments and Future Plans
  • 2.4 BD
    • 2.4.1 BD Details
    • 2.4.2 BD Major Business
    • 2.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.4.4 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 BD Recent Developments and Future Plans
  • 2.5 Grifols
    • 2.5.1 Grifols Details
    • 2.5.2 Grifols Major Business
    • 2.5.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.5.4 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Grifols Recent Developments and Future Plans
  • 2.6 Quidel
    • 2.6.1 Quidel Details
    • 2.6.2 Quidel Major Business
    • 2.6.3 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.6.4 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Quidel Recent Developments and Future Plans
  • 2.7 Meridian Bioscience
    • 2.7.1 Meridian Bioscience Details
    • 2.7.2 Meridian Bioscience Major Business
    • 2.7.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.7.4 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Meridian Bioscience Recent Developments and Future Plans
  • 2.8 Qiagen
    • 2.8.1 Qiagen Details
    • 2.8.2 Qiagen Major Business
    • 2.8.3 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.8.4 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Qiagen Recent Developments and Future Plans
  • 2.9 Eiken Chemical
    • 2.9.1 Eiken Chemical Details
    • 2.9.2 Eiken Chemical Major Business
    • 2.9.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.9.4 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Eiken Chemical Recent Developments and Future Plans
  • 2.10 OptiGene
    • 2.10.1 OptiGene Details
    • 2.10.2 OptiGene Major Business
    • 2.10.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.10.4 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 OptiGene Recent Developments and Future Plans
  • 2.11 HiberGene Diagnostic
    • 2.11.1 HiberGene Diagnostic Details
    • 2.11.2 HiberGene Diagnostic Major Business
    • 2.11.3 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.11.4 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 HiberGene Diagnostic Recent Developments and Future Plans
  • 2.12 Lucigen
    • 2.12.1 Lucigen Details
    • 2.12.2 Lucigen Major Business
    • 2.12.3 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.12.4 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Lucigen Recent Developments and Future Plans
  • 2.13 Nippon Gene
    • 2.13.1 Nippon Gene Details
    • 2.13.2 Nippon Gene Major Business
    • 2.13.3 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.13.4 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Nippon Gene Recent Developments and Future Plans
  • 2.14 Mast Group
    • 2.14.1 Mast Group Details
    • 2.14.2 Mast Group Major Business
    • 2.14.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.14.4 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Mast Group Recent Developments and Future Plans
  • 2.15 New England Biolabs
    • 2.15.1 New England Biolabs Details
    • 2.15.2 New England Biolabs Major Business
    • 2.15.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.15.4 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 New England Biolabs Recent Developments and Future Plans
  • 2.16 Ustar Biotechnologies
    • 2.16.1 Ustar Biotechnologies Details
    • 2.16.2 Ustar Biotechnologies Major Business
    • 2.16.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product and Solutions
    • 2.16.4 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Ustar Biotechnologies Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Isothermal Nucleic Acid Amplification Technology (INAAT) by Company Revenue
    • 3.2.2 Top 3 Isothermal Nucleic Acid Amplification Technology (INAAT) Players Market Share in 2022
    • 3.2.3 Top 6 Isothermal Nucleic Acid Amplification Technology (INAAT) Players Market Share in 2022
  • 3.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Overall Company Footprint Analysis
    • 3.3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Region Footprint
    • 3.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Type Footprint
    • 3.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Type (2018-2029)
  • 6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Application (2018-2029)
  • 6.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country
    • 6.3.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Country (2018-2029)
    • 6.3.2 United States Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Type (2018-2029)
  • 7.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Application (2018-2029)
  • 7.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country
    • 7.3.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 7.3.3 France Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region
    • 8.3.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Region (2018-2029)
    • 8.3.2 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 8.3.5 India Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Type (2018-2029)
  • 9.2 South America Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Application (2018-2029)
  • 9.3 South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country
    • 9.3.1 South America Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country
    • 10.3.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
  • 11.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
  • 11.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Chain
  • 12.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Upstream Analysis
  • 12.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Midstream Analysis
  • 12.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Isothermal Nucleic Acid Amplification Technology (INAAT). Industry analysis & Market Report on Isothermal Nucleic Acid Amplification Technology (INAAT) is a syndicated market report, published as Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,686.56
    4,029.84
    5,373.12
    3,201.60
    4,802.40
    6,403.20
    530,108.40
    795,162.60
    1,060,216.80
    292,772.40
    439,158.60
    585,544.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report